0000899243-23-016422.txt : 20230623 0000899243-23-016422.hdr.sgml : 20230623 20230623175220 ACCESSION NUMBER: 0000899243-23-016422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krebs Andreas CENTRAL INDEX KEY: 0001438946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40360 FILM NUMBER: 231038942 MAIL ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: SUITE 8500 CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: 212-220-6633 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: SUITE 8500 CITY: NEW YORK STATE: NY ZIP: 10007 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-21 0 0001813814 Mind Medicine (MindMed) Inc. MNMD 0001438946 Krebs Andreas C/O MIND MEDICINE (MINDMED), INC ONE WORLD TRADE CENTER, SUITE 8500 NEW YORK NY 10007 1 0 0 0 0 Common Shares 2023-06-21 4 A 0 13671 0.00 A 15107 D Stock Option (Right to Buy) 3.61 2023-06-21 4 A 0 19203 0.00 A 2033-06-20 Common Shares 19203 29748 D These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Common Share of the Issuer. The RSUs shall vest in four (4) equal quarterly installments from the grant date or upon the next Annual Meeting date, if earlier, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. On August 26, 2022, the Issuer effected a 1-for-15 reverse stock split (the" Reverse Stock Split"). The number of securities reported on the Form 4 have been adjusted to reflect the Reverse Stock Split. The shares underlying the option shall vest in twelve (12) equal monthly installments starting from the grant date or upon the next Annual Meeting date, if earlier, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. /s/ Robert Barrow, Attorney-in- Fact 2023-06-23